Home  |  About us  |  Editorial board  |  Ahead of print  | Current issue  |  Archives  |  Submit article  |  Instructions |  Search  |   Subscribe  |  Advertise  |  Contacts  |  Login 
  Users Online: 2069Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  
READING BETWEEN THE LINES
Year : 2019  |  Volume : 10  |  Issue : 1  |  Page : 42-43

Commentary on STOP DIABETES study


1 Vice President, Medical, Eris Lifesciences Ltd., Ahmedabad, Gujarat, India
2 Medical Team Lead, Diabetes and Metabolism, Boehringer Ingelheim India Pvt. Ltd., Mumbai, Maharashtra, India

Correspondence Address:
Dr. Jignesh Ved
10th Floor, Boehringer Ingelheim India Private Limited, Hallmark Plaza, Bandra East, Mumbai - 400 051, Maharashtra
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/picr.PICR_147_18

Rights and Permissions



[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed653    
    Printed10    
    Emailed0    
    PDF Downloaded109    
    Comments [Add]    

Recommend this journal